Explore
Trendline
Bristol Myers Squibb Advances Neuroscience and Oncology Pipeline with New Late-Stage Projects
Bristol Myers Squibb Advances Neuroscience and Oncology Pipeline with New Late-Stage Projects
Read More
Trendline
Big Pharma Accelerates Drug Discovery Timelines with AI Integration
Big Pharma Accelerates Drug Discovery Timelines with AI Integration
Read More
Trendline
Sanofi Considers Acquisition of U.S. Drugmaker Insmed Inc. to Address Patent Cliff
Sanofi Considers Acquisition of U.S. Drugmaker Insmed Inc. to Address Patent Cliff
Read More
Trendline
Bristol Myers Squibb Deemed Superior Dividend Stock for Retirees Over General Mills
Bristol Myers Squibb Deemed Superior Dividend Stock for Retirees Over General Mills
Read More
Trendline
Novartis Projects 5% Sales Growth Through 2031, Boosted by Key Brand Performance
Novartis Projects 5% Sales Growth Through 2031, Boosted by Key Brand Performance
Read More
Trendline
Regeneron Pharmaceuticals Defies Skeptics with Strong Performance and Clinical Milestones
Regeneron Pharmaceuticals Defies Skeptics with Strong Performance and Clinical Milestones
Read More
Trendline
Moderna Raises 2026 Revenue Growth Outlook Amidst Personalized Cancer Vaccine Program Success and New Flu Vaccine Approval
Moderna Raises 2026 Revenue Growth Outlook Amidst Personalized Cancer Vaccine Program Success and New Flu Vaccine Approval
Read More
Trendline
Cisco Systems Reports Record Q4 Revenue Amidst Margin Decline
Cisco Systems Reports Record Q4 Revenue Amidst Margin Decline
Read More
Trendline
TSMC Stocks Decline Amid Broader Market Sell-Off, Despite Record October Revenue
TSMC Stocks Decline Amid Broader Market Sell-Off, Despite Record October Revenue
Read More
Trendline
Palantir Technologies Shifts Focus to U.S. Commercial Sector as Revenue Surpasses Government Sales
Palantir Technologies Shifts Focus to U.S. Commercial Sector as Revenue Surpasses Government Sales
Read More
Trendline
Pfizer's New Drug Revenue Surges 32% in Q3 2026 Amidst Patent Cliff Concerns
Pfizer's New Drug Revenue Surges 32% in Q3 2026 Amidst Patent Cliff Concerns
Read More
Trendline
Coupang Stock Rises Amid Strong Revenue Growth and Share Repurchases, Despite Regulatory Concerns
Coupang Stock Rises Amid Strong Revenue Growth and Share Repurchases, Despite Regulatory Concerns
Read More